UPST Q2: Strong Growth and GAAP Profit, but Balance-Sheet Risk Keeps Us on WAIT

What happened

Upstart delivered robust Q2 2026 results with 50% YoY originations growth and 42% revenue growth, returning to GAAP profitability and reaffirming $1.3B revenue guidance with a 21% adjusted EBITDA margin. However, our prior deep-dive flagged $985 million in on-balance-sheet loans and a January 2026 warehouse covenant waiver as evidence of persistent funding fragility. The Seeking Alpha article acknowledges the beat but notes valuation compression relative to traditional lenders and elevated 27% short interest, signaling market skepticism about sustainability. While quarterly momentum is encouraging, the core risk remains unaddressed: without observable shrinkage in balance-sheet loans and no further covenant events, the business model stays vulnerable to funding pullbacks. We await multi-quarter evidence of de-risking and concrete bank charter milestones before considering a more constructive stance.

Implication

The Q2 beat demonstrates operating leverage and GAAP profitability, but without evidence that on-balance-sheet loans are declining and third-party funding remains dominant, risk/reward stays balanced. High short interest and valuation compression suggest the market doubts funding stability. We maintain WAIT until we see a multi-quarter trend of shrinking balance-sheet loans and no further covenant waivers, signaling the marketplace model is de-risking. The bank charter is a potential 2027 catalyst but offers no near-term support.

Thesis delta

No change. Q2 results are positive but do not alter the fundamental risk: $985M of balance-sheet loans and a recent warehouse covenant waiver keep the model vulnerable to funding pullbacks. We remain on WAIT, seeking evidence of sustained balance-sheet decline and charter milestones.